Germline mutations of BRCA1-associated RING domain (BARD1) gene in breast and/or ovarian families negative for BRCA1 and 2 alterations

Documenti analoghi

• P53 mutations in breast and ovarian carcinomas from BRCA1 and 2 mutation carriers and noncarriers
  di: Sensi, E, et al.
  Pubblicazione: (2000)
• Mutation Analysis of BRCA1 and BRCA2 in Italian Hereditary and Sporadic Forms of Breast and Ovarian Cancers: Tumor Genotype-Phenotype Correlation in Breast Cancer BRCA-Mutation Carriers
  di: Cipollini, G., et al.
  Pubblicazione: (1999)
• Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer
  di: Sauer, M, et al.
  Pubblicazione: (2005)
• Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms
  di: Stewart, Mikaela D., et al.
  Pubblicazione: (2017)
• A multi-center study to evaluate the impact of germline BRCA1 and BRCA2 mutations on ovarian cancer survival
  di: Bolton, KL, et al.
  Pubblicazione: (2012)